N/A
N=200
An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls
Cervical Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01254669 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Oct 2014
Primary outcome: Primary: The Receipt of the First HPV Vaccination — 51; 56 percentage of participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- BNI-brief Negotiated Interview (Behavioral)
- Age
- Pediatric · 11+ yrs
- Sex
- Female
- Sponsor
- Boston Medical Center
- Primary completion
- Oct 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Receipt of the First HPV Vaccination |
51; 56 | — |
| SECONDARY The Secondary Outcome Will be Maternal Knowledge About HPV Vaccine. |
10; 5 | — |
Summary
In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer than any other women in the world. Studies have shown a disparity in parental acceptance of the HPV vaccine with parents of Black adolescent girls being less likely to accept and comply with HPV immunization schedules than Whites. The objective of this study is to increase HPV immunization rates in Haitian and African American adolescent girls. The investigator's hypothesis is that a validated behavior change mechanism, brief-negotiating interviewing (BNI), will effectively increase the proportion of mothers who give consent for their daughters' HPV vaccine, which will ultimately lead to higher vaccination rates, and increase knowledge of HPV infection and the vaccine in Haitian immigrant and African American mothers.
Eligibility Criteria
Inclusion Criteria
- 11-15 HPV vaccine eligible adolescent girls
Exclusion Criteria
- Prior receipt of the HPV vaccine
- pregnant
Data sourced from ClinicalTrials.gov (NCT01254669). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.